Agilent Technologies, Inc. (NYSE:A) Shares Purchased by Sequoia Financial Advisors LLC

Sequoia Financial Advisors LLC boosted its position in Agilent Technologies, Inc. (NYSE:A) by 9.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 31,234 shares of the medical research company’s stock after buying an additional 2,720 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Agilent Technologies were worth $4,638,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Livelsberger Financial Advisory acquired a new position in Agilent Technologies in the 3rd quarter worth $28,000. Crewe Advisors LLC raised its stake in shares of Agilent Technologies by 114.8% in the 2nd quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 101 shares in the last quarter. Ridgewood Investments LLC acquired a new stake in shares of Agilent Technologies in the 2nd quarter valued at about $29,000. Riverview Trust Co acquired a new stake in shares of Agilent Technologies in the 1st quarter valued at about $41,000. Finally, Larson Financial Group LLC raised its stake in shares of Agilent Technologies by 29,300.0% in the 1st quarter. Larson Financial Group LLC now owns 294 shares of the medical research company’s stock valued at $43,000 after purchasing an additional 293 shares in the last quarter. Institutional investors and hedge funds own 87.42% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the stock. Citigroup boosted their price objective on shares of Agilent Technologies from $150.00 to $165.00 and gave the company a “buy” rating in a research report on Thursday, August 22nd. UBS Group boosted their price objective on shares of Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a research report on Thursday, August 22nd. Wolfe Research cut shares of Agilent Technologies from an “outperform” rating to a “peer perform” rating in a research report on Thursday, June 27th. Evercore ISI upped their target price on shares of Agilent Technologies from $135.00 to $145.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 1st. Finally, Bank of America upped their target price on shares of Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a research report on Thursday, August 22nd. One research analyst has rated the stock with a sell rating, five have issued a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat.com, Agilent Technologies presently has a consensus rating of “Moderate Buy” and a consensus target price of $144.36.

Insider Buying and Selling at Agilent Technologies

In other news, SVP Dominique Grau sold 9,990 shares of the stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the transaction, the senior vice president now owns 40,011 shares in the company, valued at $5,801,595. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the completion of the sale, the chief executive officer now directly owns 24,118 shares of the company’s stock, valued at $3,497,110. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Dominique Grau sold 9,990 shares of the stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the sale, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 13,953 shares of company stock worth $2,013,630. 0.33% of the stock is currently owned by company insiders.

Agilent Technologies Stock Down 2.4 %

Shares of NYSE:A opened at $133.46 on Wednesday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.37 and a current ratio of 1.78. The company has a market cap of $38.94 billion, a PE ratio of 31.55, a price-to-earnings-growth ratio of 6.96 and a beta of 1.05. Agilent Technologies, Inc. has a 52 week low of $96.80 and a 52 week high of $155.35. The firm has a 50 day simple moving average of $140.97 and a 200 day simple moving average of $138.63.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.26 by $0.06. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.56 billion. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The firm’s quarterly revenue was down 5.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.43 EPS. As a group, research analysts expect that Agilent Technologies, Inc. will post 5.24 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 23rd. Shareholders of record on Tuesday, October 1st will be paid a $0.236 dividend. The ex-dividend date is Tuesday, October 1st. This represents a $0.94 annualized dividend and a yield of 0.71%. Agilent Technologies’s dividend payout ratio is presently 22.22%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.